{"id":11720,"date":"2022-08-25T13:15:13","date_gmt":"2022-08-25T13:15:13","guid":{"rendered":"https:\/\/dev.sunpharma.com\/?page_id=11720"},"modified":"2026-04-17T21:45:41","modified_gmt":"2026-04-17T16:15:41","slug":"shareholding-pattern-76","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/shareholding-pattern-76\/","title":{"rendered":"Shareholding Pattern"},"content":{"rendered":"

[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.16″ background_image=”https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg” parallax=”on” da_disable_devices=”off|off|off” saved_tabs=”all” collapsed=”off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_fullwidth_header title=”Investor Information” header_fullscreen=”on” button_one_url=”#visionvalues” button_two_url=”#codeofconduct” _builder_version=”4.16″ title_font=”|700|||||||” title_text_color=”#f7941e” title_font_size=”40px” title_line_height=”1.2em” content_font=”||||||||” content_text_color=”#000000″ content_line_height=”1.8em” subhead_font=”||||||||” subhead_text_color=”rgba(0,0,0,0.6)” subhead_line_height=”1.4em” background_color=”rgba(255,255,255,0.7)” custom_button_one=”on” button_one_text_size=”20px” button_one_text_color=”#ffffff” button_one_bg_color=”#f7941e” button_one_border_width=”0px” button_one_font=”|||on|||||” button_one_use_icon=”off” custom_button_two=”on” button_two_text_size=”20px” button_two_text_color=”rgba(0,0,0,0.7)” button_two_bg_color=”#ffffff” button_two_border_width=”0px” button_two_font=”|||on|||||” button_two_use_icon=”off” button_two_custom_margin=”||||false|false” button_two_custom_margin_tablet=”” button_two_custom_margin_phone=”|||1px|false|false” button_two_custom_margin_last_edited=”on|desktop” button_two_custom_padding=”||||false|false” background_layout=”light” width=”50%” width_tablet=”” width_phone=”100%” width_last_edited=”on|phone” animation_style=”fade” animation_duration=”500ms” animation_delay=”300ms” title_font_tablet=”” title_font_phone=”” title_font_last_edited=”on|phone” content_font_tablet=”” content_font_phone=”” content_font_last_edited=”on|phone” global_colors_info=”{}”]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_color=”#f2f2f2″ da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.16″ _module_preset=”default” width=”90%” max_width=”2560px” custom_padding=”||2px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Shareholding Pattern<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_4,1_4,1_4,1_4″ module_class=”inves_quar” _builder_version=”4.16″ width=”90%” max_width=”2560px” custom_padding=”||0px||false|false” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text module_class=”earnings-call-recording” _builder_version=”4.27.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||” header_4_font=”|700|||||||” header_4_text_color=”#000000″ header_4_line_height=”1.4em” background_color=”#fff” custom_margin=”||||false|false” custom_padding=”10px|10px|10px|10px|true|true” hover_enabled=”0″ locked=”off” global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

2025-26<\/h4>\n

Quarter 1 (Apr-Jun)<\/a><\/p>\n

Quarter 2 (Jul-Sep)<\/a><\/p>\n

Quarter 3 (Oct-Dec)<\/a><\/p>\n

Quarter 4 (Jan-Mar)<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text module_class=”earnings-call-recording” _builder_version=”4.27.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||” header_4_font=”|700|||||||” header_4_text_color=”#000000″ header_4_line_height=”1.4em” background_color=”#fff” custom_margin=”||||false|false” custom_padding=”10px|10px|10px|10px|true|true” global_colors_info=”{}”]<\/p>\n

2024-25<\/h4>\n

Quarter 1 (Apr-Jun)<\/a><\/p>\n

Quarter 2 (Jul-Sep)<\/span><\/a><\/p>\n

Quarter 3 (Oct-Dec)<\/span><\/a><\/p>\n

Quarter 4 (Jan \u2013 Mar)<\/span><\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text module_class=”earnings-call-recording” _builder_version=”4.27.4″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||” header_4_font=”|700|||||||” header_4_text_color=”#000000″ header_4_line_height=”1.4em” background_color=”#fff” custom_margin=”||||false|false” custom_padding=”10px|10px|10px|10px|true|true” locked=”off” global_colors_info=”{}”]<\/p>\n

2023-24<\/h4>\n

Quarter 1 (Apr-Jun)<\/a><\/p>\n

Quarter 2 (Jul-Sept)<\/a><\/p>\n

Quarter 3 (Oct-Dec)<\/a><\/p>\n

Quarter 4 (Jan-Mar)<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″ _builder_version=”4.16″ global_colors_info=”{}”][et_pb_text module_class=”earnings-call-recording” _builder_version=”4.16″ _module_preset=”default” text_line_height=”1.8em” header_3_font=”|600|||||||” header_4_font=”|700|||||||” header_4_text_color=”#000000″ header_4_line_height=”1.4em” background_color=”#fff” custom_margin=”||||false|false” custom_padding=”10px|10px|10px|10px|true|true” locked=”off” global_colors_info=”{}”]<\/p>\n

2022-23<\/h4>\n

Quarter 1 (Apr-Jun)<\/a><\/p>\n

Quarter 2 (Jul-Sept)<\/a><\/p>\n

Quarter 3 (Oct-Dec)<\/a><\/p>\n

Quarter 4 (Jan-Mar)<\/a><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” da_disable_devices=”off|off|off” global_colors_info=”{}” da_is_popup=”off” da_exit_intent=”off” da_has_close=”on” da_alt_close=”off” da_dark_close=”off” da_not_modal=”on” da_is_singular=”off” da_with_loader=”off” da_has_shadow=”on”][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Shareholding Pattern2025-26 Quarter 1 (Apr-Jun) Quarter 2 (Jul-Sep) Quarter 3 (Oct-Dec) Quarter 4 (Jan-Mar)2024-25 Quarter 1 (Apr-Jun) Quarter 2 (Jul-Sep) Quarter 3 (Oct-Dec) Quarter 4 (Jan \u2013 […]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-11720","page","type-page","status-publish","hentry"],"yoast_head":"\nShareholding Pattern - Sun Pharmaceutical Industries Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/shareholding-pattern-76\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholding Pattern - Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"og:description\" content=\"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Shareholding Pattern2025-26 Quarter 1 (Apr-Jun) Quarter 2 (Jul-Sep) Quarter 3 (Oct-Dec) Quarter 4 (Jan-Mar)2024-25 Quarter 1 (Apr-Jun) Quarter 2 (Jul-Sep) Quarter 3 (Oct-Dec) Quarter 4 (Jan \u2013 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/shareholding-pattern-76\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-17T16:15:41+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/shareholding-pattern-76\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/shareholding-pattern-76\\\/\",\"name\":\"Shareholding Pattern - Sun Pharmaceutical Industries Ltd.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2022-08-25T13:15:13+00:00\",\"dateModified\":\"2026-04-17T16:15:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/shareholding-pattern-76\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/shareholding-pattern-76\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/shareholding-pattern-76\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholding Pattern\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholding Pattern - Sun Pharmaceutical Industries Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/shareholding-pattern-76\/","og_locale":"he_IL","og_type":"article","og_title":"Shareholding Pattern - Sun Pharmaceutical Industries Ltd.","og_description":"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Shareholding Pattern2025-26 Quarter 1 (Apr-Jun) Quarter 2 (Jul-Sep) Quarter 3 (Oct-Dec) Quarter 4 (Jan-Mar)2024-25 Quarter 1 (Apr-Jun) Quarter 2 (Jul-Sep) Quarter 3 (Oct-Dec) Quarter 4 (Jan \u2013 […]","og_url":"https:\/\/dev.sunpharma.com\/he\/shareholding-pattern-76\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2026-04-17T16:15:41+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/shareholding-pattern-76\/","url":"https:\/\/dev.sunpharma.com\/shareholding-pattern-76\/","name":"Shareholding Pattern - Sun Pharmaceutical Industries Ltd.","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2022-08-25T13:15:13+00:00","dateModified":"2026-04-17T16:15:41+00:00","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/shareholding-pattern-76\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/shareholding-pattern-76\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/shareholding-pattern-76\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"Shareholding Pattern"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/11720","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=11720"}],"version-history":[{"count":34,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/11720\/revisions"}],"predecessor-version":[{"id":18860,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/11720\/revisions\/18860"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=11720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}